December 1, 2015 – HSCA URGES CONGRESS TO TAKE ACTION TO ADDRESS GENERIC DRUG PRICE SPIKES
November 19, 2015 – HSCA LETTER RE: GENERIC DRUG PRICE SPIKES
October 30, 2015 – HSCA CEO STATEMENT ON CMS FINAL RULE FOR BIOSIMILAR REIMBURSEMENT
October 28, 2015 – HSCA FILES COMMENTS ON FDA BIOSIMILAR NAMING PROPOSED RULE
October 27, 2015 – HSCA COMMENTS RE: NONPROPRIETARY NAMING OF BIOLOGICAL PRODUCTS
October 26, 2015 – HSCA FILES COMMENTS ON HRSA 340B DISCOUNT DRUG PROGRAM PROPOSED RULE
October 23, 2015 – HSCA COMMENTS RE: 340B DRUG PRICING PROGRAM OMNIBUS GUIDELINES
October 7, 2015 – HSCA ENDORSES GS1 US’S ATTRIBUTE EXPLORER, HELPS HEALTHCARE INDUSTRY BETTER SERVE INFORMATION NEEDS OF SUPPLIERS AND PURCHASERS
October 2, 2015 – HSCA AND AVIA ANNOUNCE FINALISTS FOR ‘SINK OR SWIM’ SUPPLY CHAIN INNOVATION COMPETITION
September 30, 2015 – HSCA URGES FDA TO IMPLEMENT QUALITY METRICS TO MONITOR DRUG MANUFACTURING ESTABLISHMENTS, ADVANCE PRODUCT QUALITY, AND MITIGATE DRUG SHORTAGES
September 28, 2015 – HSCA LETTER RE: ANDA PRIORITIZATION TO ADDRESS GENERIC PRICE SPIKES
September 28, 2015 – HSCA COMMENTS RE: REQUEST FOR QUALITY METRICS (GUIDANCE FOR INDUSTRY)
September 16, 2015 – HEALTHCARE SUPPLY CHAIN (HSCA) STATEMENT ON HEALTH INFORMATION TECHNOLOGY INTEROPERABILITY AND PATIENT ACCESS TO RECORDS
August 4, 2015 – HEALTHCARE SUPPLY CHAIN ASSOCIATION (HSCA) STATEMENT ON THE IMPACT OF HIGH PHARMACEUTICAL COSTS ON PATIENTS AND THE HEALTHCARE SUPPLY CHAIN
July 13, 2015 – HEALTHCARE SUPPLY CHAIN ASSOCIATION (HSCA) NAMES NATIONALLY RECOGNIZED SUPPLY CHAIN LEADER TODD EBERT AS PRESIDENT & CEO
July 10, 2015 – HSCA APPLAUDS PASSAGE OF 21ST CENTURY CURES BILL
June 30, 2015 – HSCA SENDS LETTER TO FDA URGING SAME NAMES FOR BIOSIMILAR DRUGS
June 19, 2015 – HSCA JOINS GPHA, OTHER HEALTHCARE LEADERS IN SUPPORT OF FAST GENERICS ACT
June 3, 2015 – HSCA URGES FDA TO ENSURE PROPER IMPLEMENTATION OF GENERIC DRUG LEGISLATION AND TO ADDRESS GROWING BACKLOG OF NEW DRUG APPLICATIONS
May 21, 2015 – HSCA LETTER RE: GENERIC DRUG USER FEE ACT IMPLEMENTATION
April 27, 2015 – HSCA LETTER RE: LABELING CHANGES FOR APPROVED DRUGS AND BIOLOGICAL PRODUCTS
January 26, 2015 – HSCA STATEMENT ON CBO’S ANNUAL BUDGET AND ECONOMIC OUTLOOK AND THE CRITICAL ROLE OF GPOS IN CONTAINING HEALTHCARE COSTS